AxoGen Inc. Daily Stock Analysis

Daily Stock Analysis, AXGN, AxoGen Inc, priceseries

AxoGen Inc. Daily Stock Analysis
Stock Information
Open
8.97
Close
8.73
High
9.19
Low
8.70
Previous Close
9.07
Daily Price Gain
-0.34
YTD High
10.99
YTD High Date
Jan 6, 2022
YTD Low
6.98
YTD Low Date
Feb 18, 2022
YTD Price Change
-1.25
YTD Gain
-12.53%
52 Week High
23.94
52 Week High Date
May 7, 2021
52 Week Low
6.98
52 Week Low Date
Feb 18, 2022
52 Week Price Change
-10.68
52 Week Gain
-55.02%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 6. 2017
9.30
Jan 19. 2017
9.91
8 Trading Days
6.51%
Link
LONG
Apr 11. 2017
10.90
May 4. 2017
11.89
16 Trading Days
9.06%
Link
LONG
May 12. 2017
13.15
Jun 12. 2017
14.89
20 Trading Days
13.27%
Link
LONG
Jun 28. 2017
15.25
Jul 13. 2017
16.12
10 Trading Days
5.69%
Link
LONG
Aug 22. 2017
15.70
Oct 3. 2017
18.67
29 Trading Days
18.94%
Link
LONG
Oct 30. 2017
20.15
Nov 16. 2017
22.25
13 Trading Days
10.42%
Link
LONG
Nov 20. 2017
24.30
Jan 9. 2018
28.30
33 Trading Days
16.45%
Link
LONG
Feb 13. 2018
26.25
Mar 28. 2018
37.87
30 Trading Days
44.26%
Link
LONG
Apr 24. 2019
21.24
May 8. 2019
23.19
10 Trading Days
9.19%
Link
LONG
Oct 28. 2019
12.21
Nov 20. 2019
14.89
17 Trading Days
21.93%
Link
LONG
Jul 14. 2020
11.19
Jul 24. 2020
11.79
8 Trading Days
5.40%
Link
LONG
Nov 3. 2020
13.46
Nov 20. 2020
14.35
13 Trading Days
6.64%
Link
LONG
Dec 1. 2020
14.73
Dec 14. 2020
16.09
9 Trading Days
9.21%
Link
LONG
Feb 17. 2021
19.43
Mar 4. 2021
21.03
11 Trading Days
8.22%
Link
LONG
May 5. 2021
19.64
May 12. 2021
20.86
5 Trading Days
6.20%
Link
Company Information
Stock Symbol
AXGN
Exchange
NasdaqCM
Company URL
http://www.axogeninc.com
Company Phone
(386) 462-6817
CEO
Karen L. Zaderej
Headquarters
Florida
Business Address
13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL 32615
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000805928
About

AxoGen, Inc. is a regenerative medicine company, which is focused on the science, development and commercialization of technologies for peripheral nerve solutions. Its products include Avance Nerve Graft, AxoGuard Nerve Protector and AxoGuard Nerve Connector. The company was founded in 1977 and is headquartered in Alachua, FL.

Description

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading